A
6.97
-0.46 (-6.19%)
| 前收盘价格 | 7.43 |
| 收盘价格 | 7.22 |
| 成交量 | 2,332,630 |
| 平均成交量 (3个月) | 1,684,683 |
| 市值 | 3,244,527,872 |
| 价格/销量 (P/S) | 0.790 |
| 52周波幅 | |
| 利润日期 | 2 May 2025 |
| 营业毛利率 | -4.18% |
| 营业利益率 (TTM) | 10.81% |
| 稀释每股收益 (EPS TTM) | -0.380 |
| 季度收入增长率 (YOY) | 18.40% |
| 季度盈利增长率 (YOY) | -49.70% |
| 流动比率 (MRQ) | 1.40 |
| 营业现金流 (OCF TTM) | 295.10 M |
| 杠杆自由现金流 (LFCF TTM) | 253.45 M |
| 资产报酬率 (ROA TTM) | 6.24% |
| 股东权益报酬率 (ROE TTM) | -881.26% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (US) | 看跌 | 混合的 |
| Drug Manufacturers - Specialty & Generic (全球的) | 看跌 | 混合的 | |
| 股票 | Amneal Pharmaceuticals, Inc. | 混合的 | 混合的 |
AIStockmoo 评分
1.1
| 分析师共识 | -2.0 |
| 内部交易活动 | NA |
| 价格波动 | 4.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -0.5 |
| 平均 | 1.13 |
|
Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Value |
| 内部持股比例 | 48.65% |
| 机构持股比例 | 41.24% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Blackbarn Capital Partners Lp | 31 Dec 2024 | 2,850,000 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合